Viral kinetics in patients with chronic hepatitis C treated with standard or peginterferon alpha2a

Gastroenterology
S ZeuzemW K Roth

Abstract

Covalent attachment of a 40-kilodalton polyethylene glycol moiety to interferon alpha2a (peginterferon alpha2a) results in sustained delivery and reduced clearance compared with standard interferon alpha2a. The aim of the study was to compare viral kinetics in patients treated with standard or peginterferon alpha2a. Patients with chronic hepatitis C were randomly assigned to receive either standard interferon alpha2a thrice weekly (n = 16) or 180 microg peginterferon alpha2a once weekly (n = 17) for 48 weeks. HCV RNA was quantitated before and frequently during treatment. The extent of the second-phase decline of HCV RNA, representing the degradation rate of infected cells during therapy for responding patients, was 0.02 +/- 0.03 day(-1) (HCV-1), 0.88 +/- 0.64 day(-1) (HCV non-1), 0.06 +/- 0.08 day(-1) (HCV-1), and 0.44 +/- 0.33 day(-1) (HCV non-1) in patients treated with standard or peginterferon alpha2a, respectively. The second-phase decline was low (<0.05 day(-1)) in most patients without a virological end-of-treatment response, and the second-phase decline was high (>0.25 day(-1)) in all patients with sustained virological response. The degradation rate of infected cells is HCV genotype dependent. Treatment with peginterf...Continue Reading

Citations

Jul 21, 2007·Journal of Huazhong University of Science and Technology. Medical Sciences = Hua Zhong Ke Ji Da Xue Xue Bao. Yi Xue Ying De Wen Ban = Huazhong Keji Daxue Xuebao. Yixue Yingdewen Ban·Qiaoxia TongDuande Luo
Jul 2, 2003·Antiviral Research·Jean Michel Pawlotsky
May 2, 2002·Journal of Hepatology·Francesco Torre, Antonino Picciotto
Feb 3, 2006·International Journal of Clinical Practice·S Alazemi, M A Campos
May 9, 2014·International Journal of Nanomedicine·Chen-Hua Liu, Jia-Horng Kao
Oct 6, 2006·Journal of Clinical Microbiology·Ted E SchutzbankYi-Wei Tang
Jul 3, 2008·World Journal of Gastroenterology : WJG·Brian L Pearlman
Feb 23, 2010·BMC Gastroenterology·Fabrizio MecenateUNKNOWN Club Epatologi Ospedalieri (CLEO) Group
Feb 16, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ching-Sheng HsuDing-Shinn Chen
Nov 1, 2011·World Journal of Gastroenterology : WJG·Jing LuMing-Liang He
Apr 15, 2003·The Journal of General Virology·Michael FreseRalf Bartenschlager
Mar 26, 2003·Cell Death and Differentiation·E Herrmann, S Zeuzem
Jun 28, 2008·Scandinavian Journal of Gastroenterology·Huub C GelderblomHenk W Reesink
Jan 5, 2002·Expert Opinion on Investigational Drugs·S ZeuzemM Modi
Feb 26, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Thomas BergStefan Zeuzem
Jan 15, 2004·Current Gastroenterology Reports·Mark W Russo, Michael W Fried
Feb 10, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jean-Michel Pawlotsky, John G McHutchison
Oct 14, 2004·Alimentary Pharmacology & Therapeutics·G R Foster
Jun 24, 2005·The New England Journal of Medicine·Alessandra MangiaAngelo Andriulli
Apr 14, 2006·Alimentary Pharmacology & Therapeutics·U MihmS Zeuzem
Mar 16, 2006·European Journal of Gastroenterology & Hepatology·Eva Herrmann, Stefan Zeuzem
Apr 1, 2009·Expert Opinion on Drug Metabolism & Toxicology·Emi ShudoAlan S Perelson
Jan 17, 2009·Current Hepatitis Reports·Harel DahariThomas J Layden
Jan 21, 2010·The American Journal of Gastroenterology·Alexander MontoIra M Jacobson
Dec 15, 2010·Hepatitis Research and Treatment·Chun-Hao Chen, Ming-Lung Yu
Jan 11, 2012·Liver International : Official Journal of the International Association for the Study of the Liver·Alessandra Mangia, Leonardo Mottola
May 9, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Andrew H TalalAnn D Kwong
Jul 10, 2002·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Caroline M Perry, Blair Jarvis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.